Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12178417
Devices and methods for umbilical cord processing
granted -
US 12178848
Methods and compositions for the treatment of exocrine pancreatic insufficiency
granted -
US 12180251
Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders
granted -
US 12181555
3-dimensional representations of post-contrast enhanced brain lesions
granted -
US 12178868
Immunogenic compositions and uses thereof
granted -
US 12178787
T cell receptors for immunotherapy
granted -
US 12179037
Radiotherapies and uses thereof
granted -
US 12180277
LILRB4-binding antibody and methods of use thereof
granted -
US 12173061
Compositions and methods for treatment of chronic lung diseases
granted -
US 12173084
Phosphorylated dicer antibody and methods of use thereof
granted -
US 12171803
Methods of CD40 and toll like receptor immune activation
granted -
US 12173317
Use of histone modifiers to reprogram effector T cells
granted -
US 12173089
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
granted -
US 12168691
VHS format bi-specific antibodies specific for HER2 and VEGF and use thereof
granted -
US 12168678
Heme sequesting peptides and uses therefor
granted -
US 12163168
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
granted -
US 12162937
Methods of treating an inflammatory disorder by administering an antibody which binds to a connexin CX43 hemichannel
granted -
US 12161618
Methods of identifying and treating patients with HIF-2 inhibitor resistance
granted -
US 12152071
EGFL6 specific monoclonal antibodies and methods of their use
granted -
US 12151062
Compositions and devices to administer pharmaceutical compositions nasally
granted -
US 12144828
Human Kynureninase enzymes and uses thereof
granted -
US 12134648
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
granted -
US 12133924
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 12134609
Quinoline cGAS antagonist compounds
granted